2020
DOI: 10.1016/j.ejmech.2020.112217
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis and bioactivity study of N-salicyloyl tryptamine derivatives as multifunctional agents for the treatment of neuroinflammation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
37
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 35 publications
(39 citation statements)
references
References 74 publications
2
37
0
Order By: Relevance
“…On the other hand, compounds 26a and 26b reduced GFAP and Iba-1 levels in the hippocampus and displayed neuroprotection in Nissl staining in vivo . Besides, both compounds 26a and 26b had remarkable safety with LD 50 > 1000 mg/kg 41 .…”
Section: Recent Development In Anti-inflammatory Agentsmentioning
confidence: 95%
“…On the other hand, compounds 26a and 26b reduced GFAP and Iba-1 levels in the hippocampus and displayed neuroprotection in Nissl staining in vivo . Besides, both compounds 26a and 26b had remarkable safety with LD 50 > 1000 mg/kg 41 .…”
Section: Recent Development In Anti-inflammatory Agentsmentioning
confidence: 95%
“…NaBH 4 Reduction of Limonin (1). Limonin (1; 150 mg) was dissolved in dichloromethane (DCM) (15 mL), and 2.0 mL of a NaBH 4 solution (70 mg in anhydrous CH 3 OH) were added dropwise.…”
Section: Synthesis Of Compounds 1a-1gmentioning
confidence: 99%
“…[2] Lipopolysaccharide (LPS) can induce the phenotype of microglia to change and release a series of inflammatory factors, such as TNF-α, NO, iNOS, PGE2, which can cause inflammation and tissue damage. [3,4] The inflammation related diseases are still big threatens to human health, and more targeted drugs yet remain to be urgently developed.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In contrast, while another melatonin derivative with a 4-bromobenzoyl amide substitution at the N -acyl side chain (4-bromo- N -(2-(5-methoxy-1H-indol-3-yl)ethyl)benzamide, EBM) was predicted to be a substrate of CYP1A2, it displayed a potent antioxidant and neuroprotective effect [ 20 , 23 ]. Fan et al [ 24 ] also reported that N -salicyloyl tryptamine derivatives are potential anti-neuroinflammation agents that act by decreasing the production of proinflammatory mediators, NO, PGE 2 and TNF-α. These considerations prompted us to investigate and evaluate the anti-inflammatory activity of the BBM and EBM lipophilic melatonin derivatives.…”
Section: Introductionmentioning
confidence: 99%